Global Health

By Kate Greenwood
In Bioethics
Nov 25th, 2014
0 Comments
By Carl H. Coleman Cross-Posted at Bill of Health With well over 5,000 global deaths from Ebola already reported, drug developers are working fast to begin human clinical trials of promising experimental treatments.  Earlier this month, US government officials announced plans to launch a study of multiple Ebola interventions at the NIH Clinical Center, Emory […]...
By Kate Greenwood
In Ethics
Nov 13th, 2014
0 Comments
By Donna Hanrahan The recent Ebola outbreak has reignited a longstanding debate in medical ethics – in times of a pandemic, do healthcare workers have a duty to treat? The global community was confronted with similar issues during the outbreak of SARS in 2003, a time when 30% of cases were attributed to healthcare workers […]...
By Carl Coleman
In Bioethics
Nov 6th, 2013
0 Comments
At last week’s 44th Union World Conference on Lung Health in Paris, one of the main topics of discussion was the World Health Organization’s recently released 2013 Global Tuberculosis Report.  On the bright side, the report confirms a steady decline in the prevalence, incidence, and mortality of TB.  The world is on track to meet […]...
By Frank Pasquale
In Global Health
Sep 30th, 2012
0 Comments
Last week, the blog Concurring Opinions featured a symposium on Madhavi Sunder’s new book, From Goods to a Good Life: Intellectual Property and Global Justice. A chapter relevant to health law scholars is available online, here.  The chapter focuses on access to drugs in less developed countries (LDCs), and makes the following case: Not too long ago, an […]...
By Michael Ricciardelli
In Global Health
Sep 3rd, 2012
3 Comments
Recent events in New Jersey have served to highlight deficiencies in the Kidney Market. The impoverished of the world, at present, freely considering their options in a market economy, have taken to selling their kidneys, valued at roughly $160,000 on the less than open market, to kidney brokers for the approximate sum of, give or […]...